OPRK1 and Alzheimer disease: In line with this hypothesis, preliminary data (reported only in the form of citable abstracts) indicate that the topically applied KOR agonist WOL071-007 ameliorated inflammation and reduced scratching frequency in a mouse model of AD in a KOR-dependent manner, since the beneficial effects did not develop in KOR−/− animals [274].